Peptide Mythbuster · Myth #004
PEPTIDES ARE JUST A TREND
When a century of medicine meets social media skepticism
Verdict: BUSTED
01 / The claim
What people say
Peptides are just another wellness fad being pushed by influencers — they'll disappear like every other internet health trend.Social media skepticism
02 / Evidence
The data
Each point of evidence assessed against the original claim.
Refutes
Insulin Discovery
Frederick Banting and Charles Best isolated insulin in 1921. First human treatment in 1922 — a century before TikTok existed.
Refutes
FDA Approvals
Over 80 peptide drugs have received FDA approval. Another 150+ are in active clinical trials.
Refutes
Market Reality
Peptide therapeutics generate $15-20 billion annually. Trends don't sustain multi-billion dollar pharmaceutical pipelines.
Refutes
Semaglutide Success
GLP-1 peptides like semaglutide became the most prescribed diabetes and obesity treatments in history. Clinical efficacy, not marketing.
Neutral
Social Visibility
Recent social media attention has increased public awareness. Visibility isn't the same as validity — but it's not nothing.
Supports
Quality Concerns
Influencer promotion has driven demand for unregulated peptide sources. This is a legitimate concern worth acknowledging.
03 / Verdict
The ruling
BUSTED
Peptide therapeutics have been saving lives since 1922. Insulin alone predates influencers by about 80 years.
04 / Key facts
The science
- 011922 FIRST USEInsulin was first administered to a human patient over 100 years ago. Leonard Thompson, age 14, survived.
- 0280+ APPROVEDThe FDA has approved more than 80 peptide-based drugs. They treat diabetes, cancer, osteoporosis, and HIV.
- 03$50B MARKETGlobal peptide therapeutics market exceeds $50 billion. Projected to double within the decade.
- 04CENTURY OF USEPeptide medicine spans from 1922 insulin to 2024 tirzepatide. That's not a trend — it's an entire field.
05 / Deep dive
Why it matters
The conflation of peptide therapeutics with influencer culture ignores a century of medical history. Insulin, the first commercially available peptide drug, transformed Type 1 diabetes from a death sentence into a manageable condition. Today, over 80 FDA-approved peptide drugs treat conditions from cancer to metabolic disorders, generating billions in annual revenue.
06 / Sources
References
- Trends in peptide drug discoveryMuttenthaler M, King GF, Adams DJ, Alewood PF (2021). Nature Reviews Drug Discovery. View source
- Therapeutic peptides: Historical perspectives, current development trends, and future directionsLau JL, Dunn MK (2018). Bioorganic & Medicinal Chemistry. View source
- Atomic positions in rhombohedral 2-zinc insulin crystalsBlundell TL, Cutfield JF, Cutfield SM, et al. (1971). Nature. View source
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Drucker DJ (2018). Cell Metabolism. View source
- insulin
- FDA-approved
- medical-history
- therapeutics
- semaglutide